0
Medical News & Perspectives |

Studies Probe Possible Link Between Bisphosphonates and Femoral Fractures

Bridget M. Kuehn
JAMA. 2010;303(18):1795-1796. doi:10.1001/jama.2010.576.
Text Size: A A A
Published online

Extract

Conflicting data on whether long-term bisphosphonate therapy may cause a rare type of low-energy femoral fracture are creating challenges for physicians and patients in weighing the potential risks of such medications against their benefits in reducing hip fractures. But the US Food and Drug Administration (FDA) and other groups say the data so far do not support changes in prescribing practices.

Physicians have documented cases of an unusual type of femoral fracture in some patients on long-term bisphosphonate therapy. In contrast to a typical osteoporotic fracture of the femur (shown at left) with multiple fragments and apparent thinning of bone, an atypical subtrochanteric fracture (shown at right) in a patient who took bisphosphonates for 7 years is a cleaner break in apparently thick bone that occurred with minimal trauma.

Figures in this Article

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
/>
First page PDF preview

Figures

Place holder to copy figure label and caption

Graphic Jump LocationImage not available.

Physicians have documented cases of an unusual type of femoral fracture in some patients on long-term bisphosphonate therapy. In contrast to a typical osteoporotic fracture of the femur (shown at left) with multiple fragments and apparent thinning of bone, an atypical subtrochanteric fracture (shown at right) in a patient who took bisphosphonates for 7 years is a cleaner break in apparently thick bone that occurred with minimal trauma.

Tables

References

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 1

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles
Jobs
brightcove.createExperiences();